September 8th, 2017
From: Vaping360
Update: an FAQ on changes to the deeming rule, and a calendar of remaining deadlines
By Jim McDonald
On July 28, when FDA commissioner Scott Gottlieb announced a four-year delay for the final deadline to submit premarket tobacco applications (PMTA’s) for vapor products (and other newly deemed “tobacco” products), it created some confusion among vapers and vape vendors.
August 18th, 2017
From: The Washington Post
By William Wan
***
The Food and Drug Administration is expected to decide in the next two months whether to allow IQOS into the U.S. market. And that has triggered heated debate and worries among health experts about whether IQOS will help or hurt public health in this country.
Among their most pressing concerns: whether the new device will lower tobacco-related deaths, or if it is just substituting one harmful product for another.
Read Complete Article
August 9th, 2017
From: The Mercury News
By Taylor Cromwell and Justin Mattingly | Bloomberg News
***
The FDA’s initiative may upend the $130 billion American tobacco industry. It’s also likely to set off a ferocious lobbying and legal war in Washington, and push the cigarette industry to develop products that rely less on burning carcinogenic tobacco and more on delivering doses of nicotine through cleaner vapor. Smoking-related illnesses cost $300 billion a year, according to the Centers for Disease Control and Prevention.
August 2nd, 2017
From: Yale Notice & Comment | A Blog from the and the
by Micah Berman
On Friday, the FDA made an unexpected announcement that it was unveiling a “comprehensive regulatory plan” to reduce tobacco-related disease and death. The announcement was surprising in part because the Trump Administration had recently unveiled its Unified Regulatory Agenda, which emphasized deregulation and did not identify any significant planned tobacco-related action.